Executives from Frost & Sullivan are invited to attend the 7th Medical Device Market Analysis Report Conference of Medtec China2023

Executives from Frost & Sullivan are invited to attend the 7th Medical Device Market Analysis Report Conference of Medtec China2023

2023/06/05

Medtec China 2023


6month1day-3day, byInforma MarketsSponsoredMedtec China 2023The 17th International Exhibition on Medical Device Design and Manufacturing Technology was successfully held at the Suzhou International Expo Center. The total exhibition area reached36,000square meters, including16Junior College District,21Large product categories,850+Exhibitors and visitors have totaled nearly70,000person-times.

The concurrent forum of this exhibition starts from three focal points: regulations, quality, and technology, covering all aspects including design, processing, manufacturing, regulations, and testing. The conference has invited80+Panelists from regulatory authorities, hospitals and research institutes, as well as experts from leading and emerging domestic and international companies delivered keynote speeches.100+Theme Conference Coverage3DPopular topics such as printing, advanced manufacturing, implant intervention, high-end active devices, electronics, and orthopedics and dentistry.



 Innovation Technology Forum and Regulatory Summit2023Conducted during the same period, Frost & SullivanFrost & SullivanMao Hua, Partner and Managing Director of Frost & Sullivan Greater China, was invited to attend the 7th Medical Device Market Analysis Report Conference with the title2022 - 2023Delivered a speech themed "The Latest Trends and Development Opportunities in the Medical Device Industry", and served as a special advisor to the China Medical Device Industry Association&Zhao Yizhen, a partner at Yidao Capital Management and other market analysis experts, brought together with the audience to discuss the latest development trends, hotspots, growth points, and changes in the medical device market. The venue was packed with attendees, filling every seat.


Partner and Managing Director of Frost & Sullivan Greater China Region fattening


 Mao Hua pointed out that China's medical device market size ranks second globally, but per capita consumption is far lower than that of the United States, leaving significant room for development.COVID-19 pandemicDriving, China's Medical Device Export ValueIVDThe proportion has increased, and domestic high-end medical devices are gradually gaining international recognition.   A larger overseas market will gradually become an important strategic layout for domestic medical device companies.


 In recent years,   The state has continuously introduced favorable policies to promote the development of innovative medical devices and medical consumables.   The normalization of centralized procurement forces medical device companies to achieve breakthroughs through technological innovation. Favorable factors such as capital support, increased talent supply, and diversified cooperation models have also laid a solid foundation for the development of innovative medical devices in China.   "Medical devices belong to the high-end manufacturing industry and require innovative development along with collaborative manufacturing; manufacturing is one of China's strongest areas and already has a competitive advantage. After innovation catches up, China's medical device industry will shift from imitation to independent innovation and further towards globalization," said Mao Hua.


 Mao Hua then shared   He said about the development opportunities for China's medical device industry   ,   In recent years, the leading tracks for medical device investment and financing have been relatively stable, with significant growth in some tracks: the cardiovascular interventional field is innovating in multiple dimensions such as procedures, materials, and technology.   In the field of medical imaging, big data and intelligenceAIThe application trend of intraoperative image fusion technology is significant;   The era of robots is subverting various traditional surgeries and presenting development trends such as informatization, intelligence, and minimally invasive techniques;   Neural regulation technology is continuously expanding its application fields, gradually moving towards digitization, miniaturization, remote adjustment, and wireless batteryless capabilities.




About Frost & Sullivan's Healthcare Practice

 

The Healthcare Practice of Frost & Sullivan has professional analytical capabilities and extensive project experience in the life sciences field. Leveraging Frost & Sullivan's global think tank resources and its cross-industry business development platform in Greater China, Frost & Sullivan Healthcare has unique core advantages in healthcare industry investment and financing services. Frost & Sullivan Healthcare has a wide range of corporate clients in China and in the past20In the year, a vast customer network was established, and a wealth of project experience in various medical sub-fields was accumulated.


Project types include Knowledge Center projects (in-depth content, promotional activities).Pre-IPO financingprojectDCF modelValuation, Business Plan Services),IPO listingWe provide listed projects (industry consulting, clinical audits, fundraising and investment writing), market research, market value management, and strategic consulting. We also cooperate with well-known domestic and international information platforms and investment and financing institutions, offering one-stop solutions for enterprises in specialized fields such as pharmaceuticals and medical devices. Our services have received widespread attention from investors.



联系我们
联系我们
电话

业务咨询热线

(021)54075836

微信
二维码

扫码关注官方微信公众号

返回顶部
返回顶部

联系我们

×
请选择职位类别
请选择
×